Search

Your search keyword '"Ruethrich, Maria M."' showing total 9 results
Start Over Author "Ruethrich, Maria M."
9 results on '"Ruethrich, Maria M."'

1. Covid-19 triage in the emergency department 2.0: how analytics and AI transform a human-made algorithm for the prediction of clinical pathways

Author

Bartenschlager, Christina C., Grieger, Milena, Erber, Johanna, Neidel, Tobias, Borgmann, Stefan, Vehreschild, Jörg J., Steinbrecher, Markus, Rieg, Siegbert, Stecher, Melanie, Dhillon, Christine, Ruethrich, Maria M., Jakob, Carolin E. M., Hower, Martin, Heller, Axel R., Vehreschild, Maria, Wyen, Christoph, Messmann, Helmut, Piepel, Christiane, Brunner, Jens O., Hanses, Frank, and Römmele, Christoph

Published
2023
Full Text
View/download PDF

3. Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study

Author

Pilgram, Lisa, Appel, Katharina S., Ruethrich, Maria M., Koll, Carolin E. M., Vehreschild, Maria J. G. T., de Miranda, Susana M. Nunes, Hower, Martin, Hellwig, Kerstin, Hanses, Frank, Wille, Kai, Haselberger, Martina, Spinner, Christoph D., Vom Dahl, Juergen, Hertenstein, Bernd, Westhoff, Timm, Vehreschild, J. Janne, Jensen, Björn-Erik Ole, and Stecher, Melanie

Published
2023
Full Text
View/download PDF

4. AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants

Author

Giesen, Nicola, Busch, Elena, Schalk, Enrico, Beutel, Gernot, Rüthrich, Maria M., Hentrich, Marcus, Hertenstein, Bernd, Hirsch, Hans H., Karthaus, Meinolf, Khodamoradi, Yascha, Koehler, Philipp, Krüger, William, Koldehoff, Michael, Krause, Robert, Mellinghoff, Sibylle C., Penack, Olaf, Sandherr, Michael, Seggewiss-Bernhardt, Ruth, Spiekermann, Karsten, Sprute, Rosanne, Stemler, Jannik, Weissinger, Florian, Wörmann, Bernhard, Wolf, Hans-Heinrich, Cornely, Oliver A., Rieger, Christina T., and von Lilienfeld-Toal, Marie

Published
2023
Full Text
View/download PDF

5. All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort

Author

Schons, Maximilian J., Caliebe, Amke, Spinner, Christoph D., Classen, Annika Y., Pilgram, Lisa, Ruethrich, Maria M., Rupp, Jan, Nunes de Miranda, Susana M., Römmele, Christoph, Vehreschild, Janne, Jensen, Bjoern-Erik, Vehreschild, Maria, Degenhardt, Christian, Borgmann, Stefan, Hower, Martin, Hanses, Frank, Haselberger, Martina, and Friedrichs, Anette K.

Published
2022
Full Text
View/download PDF

6. The protective effect of tumor necrosis factor-alpha inhibitors in COVID-19 in patients with inflammatory rheumatic diseases compared to the general population—A comparison of two German registries

Author

Hasseli, Rebecca, primary, Hanses, Frank, additional, Stecher, Melanie, additional, Specker, Christof, additional, Weise, Tobias, additional, Borgmann, Stefan, additional, Hasselberger, Martina, additional, Hertenstein, Bernd, additional, Hower, Martin, additional, Hoyer, Bimba F., additional, Koll, Carolin, additional, Krause, Andreas, additional, von Lilienfeld-Toal, Marie, additional, Lorenz, Hanns-Martin, additional, Merle, Uta, additional, Nunes de Miranda, Susana M., additional, Pletz, Mathias W., additional, Regierer, Anne C., additional, Richter, Jutta G., additional, Rieg, Siegbert, additional, Roemmele, Christoph, additional, Ruethrich, Maria M., additional, Schmeiser, Tim, additional, Schulze-Koops, Hendrik, additional, Strangfeld, Anja, additional, Vehreschild, Maria J.G.T., additional, Voit, Florian, additional, Voll, Reinhard E., additional, Vehreschild, Jörg Janne, additional, Müller-Ladner, Ulf, additional, and Pfeil, Alexander, additional

Published
2024
Full Text
View/download PDF

7. Correction to: All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort

Author

Schons, Maximilian J., Caliebe, Amke, Spinner, Christoph D., Classen, Annika Y., Pilgram, Lisa, Ruethrich, Maria M., Rupp, Jan, Nunes de Miranda, Susana M., Römmele, Christoph, Vehreschild, Janne, Jensen, Bjoern-Erik, Vehreschild, Maria, Degenhardt, Christian, Borgmann, Stefan, Hower, Martin, Hanses, Frank, Haselberger, Martina, and Friedrichs, Anette K.

Published
2022
Full Text
View/download PDF

8. COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry

Author

Brozat, Jonathan F., Hanses, Frank, Haelberger, Martina, Stecher, Melanie, Dreher, Michael, Tometten, Lukas, Ruethrich, Maria M., Vehreschild, Janne J., Trautwein, Christian, Borgmann, Stefan, Vehreschild, Maria J. G. T., Jakob, Carolin E. M., Stallmach, Andreas, Wille, Kai, Hellwig, Kerstin, Isberner, Nora, Reuken, Philipp A., Geisler, Fabian, Nattermann, Jacob, Bruns, Tony, and LEOSS Study Group

Subjects
Liver Cirrhosis, Oncology, SARS-CoV-2, Gastroenterology, COVID-19, Humans, ddc:610, Comorbidity, Registries
Abstract

United european gastroenterology journal 10(4), 409-424 (2022). doi:10.1002/ueg2.12232, Published by Wiley, Hoboken, NJ

Published
2022

9. Correction to: All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort

Author

Schons, Maximilian J., Caliebe, Amke, Spinner, Christoph D., Classen, Annika Y., Pilgram, Lisa, Ruethrich, Maria M., Rupp, Jan, Nunes de Miranda, Susana M., Römmele, Christoph, Vehreschild, Janne, Jensen, Bjoern-Erik, Vehreschild, Maria, Degenhardt, Christian, Borgmann, Stefan, Hower, Martin, Hanses, Frank, Haselberger, Martina, and Friedrichs, Anette K.

Subjects
Microbiology (medical), Adult, Antimicrobial Stewardship, Infectious Diseases, SARS-CoV-2, Disease Progression, Correction, Humans, General Medicine, Anti-Bacterial Agents, COVID-19 Drug Treatment
Abstract

Reported antibiotic use in coronavirus disease 2019 (COVID-19) is far higher than the actual rate of reported bacterial co- and superinfection. A better understanding of antibiotic therapy in COVID-19 is necessary.6457 SARS-CoV-2-infected cases, documented from March 18, 2020, until February 16, 2021, in the LEOSS cohort were analyzed. As primary endpoint, the correlation between any antibiotic treatment and all-cause mortality/progression to the next more advanced phase of disease was calculated for adult patients in the complicated phase of disease and procalcitonin (PCT) ≤ 0.5 ng/ml. The analysis took the confounders gender, age, and comorbidities into account.Three thousand, six hundred twenty-seven cases matched all inclusion criteria for analyses. For the primary endpoint, antibiotic treatment was not correlated with lower all-cause mortality or progression to the next more advanced (critical) phase (n = 996) (both p 0.05). For the secondary endpoints, patients in the uncomplicated phase (n = 1195), regardless of PCT level, had no lower all-cause mortality and did not progress less to the next more advanced (complicated) phase when treated with antibiotics (p 0.05). Patients in the complicated phase with PCT 0.5 ng/ml and antibiotic treatment (n = 286) had a significantly increased all-cause mortality (p = 0.029) but no significantly different probability of progression to the critical phase (p 0.05).In this cohort, antibiotics in SARS-CoV-2-infected patients were not associated with positive effects on all-cause mortality or disease progression. Additional studies are needed. Advice of local antibiotic stewardship- (ABS-) teams and local educational campaigns should be sought to improve rational antibiotic use in COVID-19 patients.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results